IPO Calendar
Lead Manager
- J P Morgan Chase (482)
- Goldman Sachs (458)
- Morgan Stanley (413)
- Bank of America Merrill Lynch (354)
- Citigroup (222)
- Jefferies (211)
- Credit Suisse (180)
- Barclays (150)
- Cowen and Company (145)
- Deutsche Bank (81)
- Piper Jaffray (70)
- Leerink Partners (69)
- Stifel (65)
- UBS Investment Bank (52)
- Evercore (51)
- RBC Capital (50)
- BMO Capital (49)
- Wells Fargo (45)
- William Blair (37)
- Raymond James (36)
More +
IPO - Pricing (10)
Leerink Partners
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 14 | FibroGen Inc | Health-Care | 18 | 8 | CITI | GS | LRNK | 79.5% | 22.2% | ||
| Oct 22 | DBV Technologie | Health-Care | 21.6 | 4 | CITI | LRNK | 29% | 5.8% | |||
| Oct 15 | Forward Pharma | Health-Care | 21 | 10 | JEFF | LRNK | RBC | 38.7% | -16.7% | ||
| Oct 3 | Journey Medical | Health-Care | 16 | 7 | CITI | LRNK | 72.1% | -2.8% | |||
| Oct 2 | Calithera Biosc | Health-Care | 10 | 8 | CITI | LRNK | 57.9% | -5.9% | |||
| Sep 18 | ProQR Therapeut | Health-Care | 13 | 7 | DB | LRNK | 90.1% | 13.3% | |||
| Sep 12 | Affimed N.V. | Health-Care | 7 | 8 | BMO | JEFF | LRNK | 44.6% | -18.6% | ||
| Jul 17 | CareDx Inc. | Health-Care | 10 | 4 | LRNK | PPRJ | 39.9% | -9.5% | |||
| Jun 19 | Ardelyx Inc. | Health-Care | 14 | 4 | CITI | LRNK | 36.9% | 0.8% | |||
| Feb 5 | uniQure N.V. | Health-Care | 17 | 5 | JEFF | LRNK | LRNK | 86.8% | -14.1% | ||
*
Lead manager or one of top three managers in an underwriting team.